These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5833611)

  • 1. Tryptamine metabolism in depression.
    Coppen A; Shaw DM; Malleson A; Eccleston E; Gundy G
    Br J Psychiatry; 1965 Oct; 111(479):993-8. PubMed ID: 5833611
    [No Abstract]   [Full Text] [Related]  

  • 2. Indoleamine metabolism in affective disorders: excretion of tryptamine, indoleacetic acid and 5-hydroxy-indoleacetic acid in depressive states.
    McNamee HB; Moody JP; Naylor GJ
    J Psychosom Res; 1972 Feb; 16(1):63-70. PubMed ID: 5058989
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of tranylcypromine and pargyline on brain tryptamine.
    Tabakoff B; Moses F; Philips SR; Boulton AA
    Experientia; 1977 Mar; 33(3):380-1. PubMed ID: 870336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transformation of tryptamine by Aspergillus niger].
    Dvornikova TP; Skriabin GK; Suvorov NN
    Mikrobiologiia; 1968; 37(2):228-32. PubMed ID: 5732065
    [No Abstract]   [Full Text] [Related]  

  • 5. Time studies on the effects of tranylcypromine plus tryptophan on formation of tryptamine and 5-hydroxytryptamine in rat brain.
    Hay JL; McKim HR; Baker GB; Dewhurst WG
    Proc West Pharmacol Soc; 1982; 25():133-5. PubMed ID: 7122487
    [No Abstract]   [Full Text] [Related]  

  • 6. On the ability of Taphrina deformans to produce indoleacetic acid from tryptophan by way of tryptamine.
    Perley JE; Stowe BB
    Plant Physiol; 1966 Feb; 41(2):234-7. PubMed ID: 5908633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schizophrenic behavior and urinary tryptophan metabolites associated with cysteine given with and without a monoamine oxidase inhibitor (tranylcypromine).
    Spaide J; Tanimukai H; Ginther R; Bueno J; Himwich HE
    Life Sci; 1967 Mar; 6(5):551-60. PubMed ID: 4226702
    [No Abstract]   [Full Text] [Related]  

  • 8. 5-Hydroxytryptamine and tryptamine pathways in scleroderma.
    Stachow A; Jablonska S; Skiendzielewska A
    Br J Dermatol; 1977 Aug; 97(2):147-54. PubMed ID: 911677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tryptophan metabolism in depressive illness.
    Coppen A; Brooksbank BW; Eccleston E; Peet M; White SG
    Psychol Med; 1974 May; 4(2):164-73. PubMed ID: 4829609
    [No Abstract]   [Full Text] [Related]  

  • 10. Formation of indoleacetic acid by intestinal anaerobes.
    Chung KT; Anderson GM; Fulk GE
    J Bacteriol; 1975 Oct; 124(1):573-5. PubMed ID: 1236846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical correlates of behavior in schizophrenic patients. Schizophrenic patients receiving tryptophan and methionine or methionine together with a monoamine oxidase inhibitor.
    Berlet HH; Matsumoto K; Pscheidt GR; Spaide J; Bull C; Himwich HE
    Arch Gen Psychiatry; 1965 Dec; 13(6):521-31. PubMed ID: 5841751
    [No Abstract]   [Full Text] [Related]  

  • 12. The contribution of tryptamine to the behavioural effects of l-Tryptophan in tranylcypromine-treated rats.
    Marsden CA; Curzon G
    Psychopharmacology (Berl); 1978 Apr; 57(1):71-6. PubMed ID: 149328
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on the tryptophan metabolism of Streptomycetes. II. Quantitative determination of appearing tryptophan metabolites and their metabolism].
    Teuscher G; Teuscher E
    Acta Biol Med Ger; 1967; 19(2):211-9. PubMed ID: 5591562
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative behavioral and biochemical effects of tranylcypromine and cysteine on normal controls and schizophrenic patients.
    Narasimhachari N; Heller B; Spaide J; Haskovec L; Fujimori M; Tabushi K; Himwich HE
    Life Sci I; 1970 Sep; 9(18):1021-32. PubMed ID: 5478406
    [No Abstract]   [Full Text] [Related]  

  • 15. On the condensation of tryptamine & indole-3-acetaldehyde.
    Das PK; Dutta PK; Guha SR
    Indian J Biochem Biophys; 1983 Dec; 20(6):390-1. PubMed ID: 6674123
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study of the enterochromaffin system and tryptamine metabolism in man].
    Gasbarrini G; Melchionda N; Benfenati F; Mantovani BA; Aureli G
    Bull Sci Med (Bologna); 1969; 141(2):85-118. PubMed ID: 5358199
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pathologic deviations of tryptophan metabolism and their biochemical examination].
    Dreux C
    Ann Biol Clin (Paris); 1968; 26(1):57-72. PubMed ID: 4231425
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of tryptophan uptake in Aspergillus fumigatus by tryptamine.
    Gupta AR; Rao KK
    Experientia; 1977 Jul; 33(7):853-4. PubMed ID: 330196
    [No Abstract]   [Full Text] [Related]  

  • 19. Indoleamines and affective disorders.
    Coppen A
    J Psychiatr Res; 1972 Sep; 9(3):163-71. PubMed ID: 5083172
    [No Abstract]   [Full Text] [Related]  

  • 20. Biogenic amines derived from tryptophan in systemic and cutaneous scleroderma.
    Stachów A; Jabłońska S; Skiendzielewska A
    Acta Derm Venereol; 1979; 59(1):1-5. PubMed ID: 84460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.